CMS has announced it is now accepting MIPS Exception applications for clinicians and groups who have been impacted by public health emergency in 2022.
Every year the sky is falling, at least that’s how it seems. I have been attending Executive War College since the 90s and thank God we’ve been able to change and adapt with the dramas of running a healthcare business. These are things I learned from presentations by Robert Michel, editor-in-chief of the Dark Report, and others:
Due to a number of COVID funds being exhausted or close to tapped out, this is likely to be the final extension. Here are some items to keep in mind as labs and pathologists prepare for the potential end of the PHE.
UnitedHealth says it plans to complete the acquisition of Change Healthcare despite an ongoing legal challenge from the Department of Justice (DOJ) that aims to block the deal.
Letters from Cigna dated April 1st, 2022, are not an April Fools’ Prank. It appears that Cigna is attempting a new additional tactic to manage their payment of the Professional Component of Clinical Pathology (PCCP).
As Vachette Pathology celebrates its 20th anniversary, founder Mick Raich looks back on what he's learned during that time.
"Gone may be the days where one person who was more broadly trained could effectively advise whole laboratories comprehensively on what patients need and how to go about arranging that as an in-house offering," says Tara Luellen, Vice President of Lab Director Services.
The HRSA Uninsured Program said claims for COVID testing and treatment will stop being accepted on March 22 at 11:59 p.m.
Impacted providers should expect to see 25% of their total Medicare payments to be recouped during the first 11 months of the repayment period. If repayment has not been completed within that timeframe, the recoupment rate will increase to 50% for 6 months.
When a client went uncompensated for months of work due to a biller’s breach of contract, we were able to fight on their behalf to recover a $25,000 settlement.
There are some interesting changes in the medical billing world surrounding artificial intelligence (AI). There is an AI war going on with payers and billers in the revenue cycle management (RCM) arena and the winner will be the one who invests in AI quickest and maintains their edge in technology. We are just beginning to see this technology utilized, but several firms are already in the game.
On Feb. 11, the FDA authorized the emergency use of the monoclonal antibody bebtelovimab for the treatment of COVID-19 in adult and pediatric patients.
The College of American Pathologists (CAP) has joined six other provider advocacy groups in formally requesting UnitedHealthcare (UHC) forgo its Designated Diagnostic Provider (DDP) program that was launched last summer in an attempt to further tighten the payer's network and direct patients to preferred laboratories.
Early 2020 Merit-based Incentive Payment data released this week by CMS shows pandemic reporting flexibility is likely to keep the penalty pool small.
The Covid-19 Public Health Emergency has been extended for an additional 90 days after HHS Secretary Xavier Becerra signed off on the extension late last week.
Who's reviewing revenue strategy with you at this time?
Are you billing all the correct CPT codes? You’d be surprised at what you might be missing. We will review your Fee Schedule/Charge Master at no cost.
That’s right. For free.